← Back to Search

Behavioural Intervention

SurePace Powered Walker User for Cerebral Palsy

N/A
Waitlist Available
Led By Jason Burkholder, Ph.D.
Research Sponsored by Barron Associates, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five minutes
Awards & highlights

Study Summary

This trial is testing a computer-driven walker that will help people with walking disabilities by reducing the amount of energy needed to walk.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and five minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Metabolic Cost (oxygen consumption)

Trial Design

1Treatment groups
Experimental Treatment
Group I: SurePace Powered Walker UserExperimental Treatment1 Intervention
Before any formal experiments are conducted, participants will be given an opportunity to "train" with the new powered walker for a pre-defined period of time to eliminate the confounding effects of being unfamiliar with using the device. (See the description of UVA's facilities and Protection of Human Subjects document for additional discussion of safety measures/protocols and Institutional Review Board procedures.) Experiments will consist of one-hour sessions (with adequate rest periods between trials and time for evaluations) in which participants will be asked to walk at a self-selected (comfortable) walking speed through a pre-defined 8 m x 4 m oval course.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SurePace Powered Walker User
2020
N/A
~50

Find a Location

Who is running the clinical trial?

Barron Associates, Inc.Lead Sponsor
6 Previous Clinical Trials
186 Total Patients Enrolled
University of VirginiaOTHER
759 Previous Clinical Trials
1,245,538 Total Patients Enrolled
5 Trials studying Cerebral Palsy
516 Patients Enrolled for Cerebral Palsy
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,494,236 Total Patients Enrolled
7 Trials studying Cerebral Palsy
1,025 Patients Enrolled for Cerebral Palsy

Media Library

Intelligent and Adaptive Control (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05465239 — N/A
Cerebral Palsy Research Study Groups: SurePace Powered Walker User
Cerebral Palsy Clinical Trial 2023: Intelligent and Adaptive Control Highlights & Side Effects. Trial Name: NCT05465239 — N/A
Intelligent and Adaptive Control (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05465239 — N/A
~10 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top